Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives
Top Cited Papers
Open Access
- 7 January 2026
- journal article
- review article
- Published by Springer Nature in Molecular Biomedicine
- Vol. 7 (1) , 2
Abstract
Inflammatory bowel disease (IBD) is a heterogeneous group of disorders characterized primarily by chronic relapsing intestinal inflammation, encompassing Crohn’s disease (CD) and ulcerative colitis (UC), affecting individuals across age groups with variable clinical manifestations. With the advancement of global industrialization, its incidence continues to rise, particularly in newly industrialized regions, which not only severely impairs patients' quality of life but also emerges as a major public health concern threatening digestive system health, accompanied by a substantial healthcare burden, thus necessitating the development of more effective and safer individualized treatment strategies. This review summarizes the pathogenesis of IBD, including intestinal mucosal immune dysregulation, intestinal barrier damage, gut microbiota dysbiosis, reactive oxygen species (ROS) homeostasis imbalance, and the complex crosstalk between genetic and environmental factors; however, clinical treatment still faces numerous challenges: 30%-40% of patients exhibit primary or secondary non-response to existing therapeutic regimens such as biologics and small-molecule drugs, and prolonged administration tends to induce significant side effects. Further integrated herein are emerging strategies such as ROS modulators, novel immune-targeted modulation, intestinal barrier repair agents, microbiota-directed interventions, multi-omics-based precision medicine, and artificial intelligence (AI)-assisted therapy, which represent key directions to address the limitations of traditional treatments. This article begins with an overview of basic pathological mechanisms and offers a comprehensive overview of relevant therapeutic approaches and future development directions, aiming to facilitate the transition of the field from traditional generalized therapies to personalized precision medicine and to bridge the long-standing gap between basic research and clinical practice.Keywords
Funding Information
- National Natural Science Foundation of China (Grant No.82400649)
- Science-Health Joint Medical Scientific Research Project of Chongqing ((2024QNXM036)
- Science-Health Joint Medical Scientific Research Project of Chongqing (2024ZDXM009)
- National Key R&D Program of China (2023YFC2507300)
This publication has 582 references indexed in Scilit:
- Atg7 in CD4+ T cells improves intestinal mucosal inflammation by regulating Ets1‐mediated T cell differentiationClinical and Translational Medicine, 2025
- Menstrual Blood‑Derived Endometrial Stem Cells Protect the Integrity of the Intestinal Barrier by Inhibiting the NF‐κB/Snail Signaling PathwayCell Biology International, 2025
- Inulin Protects Caco‐2 Cells Against Lipopolysaccharide‐Induced Epithelial Barrier DysfunctionFood Science & Nutrition, 2025
- Delivery of Encapsulated Intelligent Engineered Probiotic for Inflammatory Bowel Disease TherapyAdvanced Healthcare Materials, 2024
- Investigate the metabolic changes in intestinal diseases by employing a 1 H ‐ NMR ‐based metabolomics approach on Caco‐2 cells treated with cedrolBioFactors, 2024
- Deubiquitination of RIPK2 by OTUB2 augments NOD2 signalling and protective effects in intestinal inflammationClinical and Translational Medicine, 2024
- Precisely Inhibiting Excessive Intestinal Epithelial Cell Apoptosis to Efficiently Treat Inflammatory Bowel Disease with Oral Pifithrin‐α Embedded Nanomedicine (OPEN)Advanced Materials, 2023
- Refractory neutrophils and monocytes in patients with inflammatory bowel disease after repeated bouts of prolonged exerciseCytometry Part B: Clinical Cytometry, 2021
- Melanoma Risk in Patients Treated With Biologic Therapy for Common Inflammatory DiseasesJAMA Dermatology, 2020
- Mice lacking myosin IXb, an inflammatory bowel disease susceptibility gene, have impaired intestinal barrier function and superficial ulceration in the ileumCytoskeleton, 2016